Japanese guidelines for allergic conjunctival diseases 2020. 2020

Dai Miyazaki, and Etsuko Takamura, and Eiichi Uchio, and Nobuyuki Ebihara, and Shigeaki Ohno, and Yuichi Ohashi, and Shigeki Okamoto, and Yoshiyuki Satake, and Jun Shoji, and Kenichi Namba, and Kazumi Fukagawa, and Atsuki Fukushima, and Hiroshi Fujishima, and , and
Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, Tottori, Japan. Electronic address: miyazaki-ttr@umin.ac.jp.

The definition, classification, pathogenesis, test methods, clinical findings, criteria for diagnosis, and therapies of allergic conjunctival disease are summarized based on the Guidelines for Clinical Management of Allergic Conjunctival Disease 2019. Allergic conjunctival disease is defined as "a conjunctival inflammatory disease associated with a Type I allergy accompanied by some subjective or objective symptoms." Allergic conjunctival disease is classified into allergic conjunctivitis, atopic keratoconjunctivitis, vernal keratoconjunctivitis, and giant papillary conjunctivitis. Representative subjective symptoms include ocular itching, hyperemia, and lacrimation, whereas objective symptoms include conjunctival hyperemia, swelling, folliculosis, and papillae. Patients with vernal keratoconjunctivitis, which is characterized by conjunctival proliferative changes called giant papilla accompanied by varying extents of corneal lesion, such as corneal erosion and shield ulcer, complain of foreign body sensation, ocular pain, and photophobia. In the diagnosis of allergic conjunctival diseases, it is required that type I allergic diathesis is present, along with subjective and objective symptoms accompanying allergic inflammation. The diagnosis is ensured by proving a type I allergic reaction in the conjunctiva. Given that the first-line drug for the treatment of allergic conjunctival disease is an antiallergic eye drop, a steroid eye drop will be selected in accordance with the severity. In the treatment of vernal keratoconjunctivitis, an immunosuppressive eye drop will be concomitantly used with the abovementioned drugs.

UI MeSH Term Description Entries
D003229 Conjunctival Diseases Diseases involving the CONJUNCTIVA. Conjunctival Disease,Disease, Conjunctival,Diseases, Conjunctival
D003233 Conjunctivitis, Allergic Conjunctivitis due to hypersensitivity to various allergens. Allergic Conjunctivitis,Conjunctivitis, Atopic,Conjunctivitis, Giant Papillary,Conjunctivitis, Vernal,Keratoconjunctivitis, Vernal,Allergic Conjunctivitides,Atopic Conjunctivitides,Atopic Conjunctivitis,Conjunctivitides, Allergic,Conjunctivitides, Atopic,Conjunctivitides, Giant Papillary,Conjunctivitides, Vernal,Giant Papillary Conjunctivitides,Giant Papillary Conjunctivitis,Keratoconjunctivitides, Vernal,Papillary Conjunctivitides, Giant,Papillary Conjunctivitis, Giant,Vernal Conjunctivitides,Vernal Conjunctivitis,Vernal Keratoconjunctivitides,Vernal Keratoconjunctivitis
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019468 Disease Management A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596) Disease Managements,Management, Disease,Managements, Disease

Related Publications

Dai Miyazaki, and Etsuko Takamura, and Eiichi Uchio, and Nobuyuki Ebihara, and Shigeaki Ohno, and Yuichi Ohashi, and Shigeki Okamoto, and Yoshiyuki Satake, and Jun Shoji, and Kenichi Namba, and Kazumi Fukagawa, and Atsuki Fukushima, and Hiroshi Fujishima, and , and
July 2020, Allergology international : official journal of the Japanese Society of Allergology,
Dai Miyazaki, and Etsuko Takamura, and Eiichi Uchio, and Nobuyuki Ebihara, and Shigeaki Ohno, and Yuichi Ohashi, and Shigeki Okamoto, and Yoshiyuki Satake, and Jun Shoji, and Kenichi Namba, and Kazumi Fukagawa, and Atsuki Fukushima, and Hiroshi Fujishima, and , and
April 2017, Allergology international : official journal of the Japanese Society of Allergology,
Dai Miyazaki, and Etsuko Takamura, and Eiichi Uchio, and Nobuyuki Ebihara, and Shigeaki Ohno, and Yuichi Ohashi, and Shigeki Okamoto, and Yoshiyuki Satake, and Jun Shoji, and Kenichi Namba, and Kazumi Fukagawa, and Atsuki Fukushima, and Hiroshi Fujishima, and , and
July 2020, Allergology international : official journal of the Japanese Society of Allergology,
Dai Miyazaki, and Etsuko Takamura, and Eiichi Uchio, and Nobuyuki Ebihara, and Shigeaki Ohno, and Yuichi Ohashi, and Shigeki Okamoto, and Yoshiyuki Satake, and Jun Shoji, and Kenichi Namba, and Kazumi Fukagawa, and Atsuki Fukushima, and Hiroshi Fujishima, and , and
July 2020, Allergology international : official journal of the Japanese Society of Allergology,
Dai Miyazaki, and Etsuko Takamura, and Eiichi Uchio, and Nobuyuki Ebihara, and Shigeaki Ohno, and Yuichi Ohashi, and Shigeki Okamoto, and Yoshiyuki Satake, and Jun Shoji, and Kenichi Namba, and Kazumi Fukagawa, and Atsuki Fukushima, and Hiroshi Fujishima, and , and
March 2011, Allergology international : official journal of the Japanese Society of Allergology,
Dai Miyazaki, and Etsuko Takamura, and Eiichi Uchio, and Nobuyuki Ebihara, and Shigeaki Ohno, and Yuichi Ohashi, and Shigeki Okamoto, and Yoshiyuki Satake, and Jun Shoji, and Kenichi Namba, and Kazumi Fukagawa, and Atsuki Fukushima, and Hiroshi Fujishima, and , and
February 2006, Nippon Ganka Gakkai zasshi,
Dai Miyazaki, and Etsuko Takamura, and Eiichi Uchio, and Nobuyuki Ebihara, and Shigeaki Ohno, and Yuichi Ohashi, and Shigeki Okamoto, and Yoshiyuki Satake, and Jun Shoji, and Kenichi Namba, and Kazumi Fukagawa, and Atsuki Fukushima, and Hiroshi Fujishima, and , and
January 2023, Allergology international : official journal of the Japanese Society of Allergology,
Dai Miyazaki, and Etsuko Takamura, and Eiichi Uchio, and Nobuyuki Ebihara, and Shigeaki Ohno, and Yuichi Ohashi, and Shigeki Okamoto, and Yoshiyuki Satake, and Jun Shoji, and Kenichi Namba, and Kazumi Fukagawa, and Atsuki Fukushima, and Hiroshi Fujishima, and , and
September 2014, Allergology international : official journal of the Japanese Society of Allergology,
Dai Miyazaki, and Etsuko Takamura, and Eiichi Uchio, and Nobuyuki Ebihara, and Shigeaki Ohno, and Yuichi Ohashi, and Shigeki Okamoto, and Yoshiyuki Satake, and Jun Shoji, and Kenichi Namba, and Kazumi Fukagawa, and Atsuki Fukushima, and Hiroshi Fujishima, and , and
April 2017, Allergology international : official journal of the Japanese Society of Allergology,
Dai Miyazaki, and Etsuko Takamura, and Eiichi Uchio, and Nobuyuki Ebihara, and Shigeaki Ohno, and Yuichi Ohashi, and Shigeki Okamoto, and Yoshiyuki Satake, and Jun Shoji, and Kenichi Namba, and Kazumi Fukagawa, and Atsuki Fukushima, and Hiroshi Fujishima, and , and
April 2017, Allergology international : official journal of the Japanese Society of Allergology,
Copied contents to your clipboard!